PHL 424 Antimicrobials 2nd Lecture By Abdelkader Ashour, Ph.D. Phone: 4677212 Email: aeashour@ksu.edu.sa.

Slides:



Advertisements
Similar presentations
Tetracyclines Are bacteriostatic antibiotics having broad spectrum of activity. Isolated from Streptomyces bacteria. First one isolated was chlortetracycline.
Advertisements

TETRACYCLINES Mechanism of action Inhibit protein synthesis by binding reversibly to 30 s subunit Short acting Tetracycline Oxytetracycline t1/2 6-8 hr.
PHL 424 Antimicrobials 9 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Tetracyclines. History The development of the tetracycline antibiotics was the result of a systemic screening of soil specimens collected from many parts.
PHL 424 Antimicrobials 7th Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology-1 PHL 211 2nd Term 1st Lecture Local Anesthetics I By Abdelkader Ashour, Ph.D. Phone:
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
PHL 424 Antimicrobials 6 th Lecture By Abdelkader Ashour, Ph.D. Phone:
PHL 424 Antimicrobials 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
Antibiotics Biotechnology II. Univ S. Carolina Antibiotics Disrupt Cell Wall Synthesis, Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
Antibiotics Bio February 2010 Ethan Richman Ben Kwak Ampicillin, Tetracyclin, and Chloramphenicol.
Drugs acting on bacterial protein biosynthesis
ANTIDIARRHOEAL AGENT What is diarrhoea ? Increased frequency or increased fluidity of bowl movements in a given individual is called diarrhoea. What.
1 Inhibitors of Protein Synthesis Bacterial cells are 50% protein by dry weight –Inhibition of protein synthesis leads to cessation of growth or cell death.
12 th Lecture By Abdelkader Ashour, Ph.D. Phone: PHL 424 Antimicrobials.
PHL 424 Antimicrobials 8 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Drug Disposition Porofessor Hanan hager Dr.Abdul latif Mahesar College of medicine King Saud University.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
AMINOGLYCOSIDES The different members of this group share many properties in common. The different members of this group share many properties in common.
PHARMACOKINETICS.
PHL 424 Antimicrobials 5 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology Department
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Urinary Antiseptics. Organisms  Escherichia coli  Proteus  Pseudomonas species  streptococci  Klebsiella  Enterococcus  Staphylococcus epidermidis.
CHLORAMPHENICOL First broad spectrum antibiotic. First broad spectrum antibiotic. Originally isolated in Originally isolated in Now produced.
PHARMACOKINETICS Part 3.
PHL 424 Antimicrobials 4th Lecture By Abdelkader Ashour, Ph.D. Phone:
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
PHARMA TEAM 428 ANTIBIOTICS(4) Pharma Team 428.
Antibiotics act by inhibition of protein synthesis د. شذى هاني Ph.D. candidate (pharmacology )
Chemotherapy Of Mycobacterial Infections Dr.Mohamed daood PhD student in Pharmacology.
Treatment Of Respiratory Tract infections. Prof. Azza ELMedany Department of Pharmacology Ext
INHIBITOR of BACTERIAL PROTEIN SYNTHESIS. BACTERIAL PROTEIN SYNTHESIS The selectivity for bacterial protein synthesis is caused by differences in the.
Protein synthesis inhibitors TETRACYCLINES. Learning Objectives After these sessions, you will be able to:  classify tetracyclines on the basis of source.
Treatment of Respiratory Tract infections. Prof. Azza EL-Medany.
PRINCIPLES OF ANTIBIOTIC THERAPY
Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and Others.
Antimycobacterial Drugs September Mycobacteria Mycobacteria are intrinsically resistant to most antibiotics. Because they grow slowly compared with.
DNA gyrase inhibitors Quinolones
Protein synthesis Inhibitors
Protein Synthesis Inhibitors
Excretion of drugs.
(Tetracyclines & Linezolid) Laith Mohammed Abbas Al-Huseini
Miscellaneous Antibiotics
TETRACYCLINES Broad spectrum antibiotics
Aminoglycosides.
Lecture 1 Antimicrobial drugs.
Inhibitors of Protein Synthesis
Understanding the Basics of Pharmacology
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms . CHEMOTHERAPEUTIC.
Cephalosporin and Other Cell Wall Synthesis Inhibitors
Cell Wall Synthesis Inhibitors (Penicillins)
Course Coordinator Jamaluddin Shaikh, Ph.D.
Cephalosporin and Cell Wall Synthesis Inhibitors
Course Coordinator Jamaluddin Shaikh, Ph.D.
Other Protein Synthesis Inhibitor
Pharmacokinetics and Factors of Individual Variation
Cell Wall Synthesis Inhibitors (Penicillins)
Basic Biopharmaceutics
Broad-spectrum antibiotics
Cephalosporin and Cell Wall Synthesis Inhibitors
Chapter 41 Tetracyclines and chloramphenicol
Treatment of Respiratory Tract Infections
Other Protein Synthesis Inhibitor
Other β-lactam A. Carbapenems:
Fluoroquinolone Nalidixic acid is the predecessor to all fluoroquinolones, a class of man-made antibiotics. Fluoroquinolones in use today typically offer.
2- Tetracyclines Classification
Pharmaceutical chemistry Antibacterial Antibiotics Tetracyclines
ANTIBIOTICS They are divided into four categories based on their bacteriostatic or bactericidal effect(mode of action) on various structures and macromolecules.
Presentation transcript:

PHL 424 Antimicrobials 2nd Lecture By Abdelkader Ashour, Ph.D. Phone: 4677212 Email: aeashour@ksu.edu.sa

Inhibitors of bacterial protein synthesis, Tetracyclines Tetracyclines are safe, inexpensive broad- spectrum bacteriostatic antibiotics that inhibit protein synthesis The basic tetracycline structure consists of four benzene rings with various substituent on each ring (C22H24N2O8; M.Wt. 444.43)

Inhibitors of bacterial protein synthesis, Tetracyclines Tetracyclines are classified as: Short-acting: This includes oxytetracycline (a natural product produced by Streptomyces rimosus) & tetracycline (a semisynthetic derivative of chlortetracycline, produced by Streptomyces aureofaciens Intermediate acting: This includes demeclocycline (the product of a mutant strain of Strep. Aureofaciens) and methacycline (semisynthetic) Long-acting, e.g., doxycycline and minocycline which are semisynthetic derivatives The almost complete absorption and slow excretion of doxycycline and minocycline allow for once-daily dosing A newly approved tetracycline analog, tigecycline, Is a semisynthetic derivative of minocycline

Inhibitors of bacterial protein synthesis, Tetracyclines, contd. MOA: Tetracyclines enter microorganisms through cell wall in part by passive diffusion and in part by an energy-dependent process of active transport Susceptible cells concentrate the drug intracellularly Tetracyclines then bind reversibly to the 30S subunit of the bacterial ribosome, blocking the binding of aminoacyl-tRNA to the acceptor site on the mRNA-ribosome complex This prevents addition of amino acids to the growing peptide, with subsequent inhibition of protein synthesis

Inhibitors of bacterial protein synthesis, Tetracyclines, contd. Antimicrobial actions: Tetracyclines are active against many G+ve & G-ve bacteria, including anaerobes, rickettsiae, chlamydiae, mycoplasmas Minocycline is usually the most active followed by doxycycline They are also active against some protozoa, e.g., amebas The antibacterial activities of most tetracyclines are similar except that tetracycline-resistant strains may remain susceptible to doxycycline or minocycline, drugs that are less rapidly transported by the pump that is responsible for resistance Resistance mechanisms : Decreased intracellular accumulation due to either decreased influx or increased efflux by an active transport protein pump … (the most important) Ribosome protection due to production of proteins that interfere with tetracycline binding to the ribosome Enzymatic inactivation of tetracyclines Resistance is primarily plasmid-mediated and often is inducible

Inhibitors of bacterial protein synthesis, Tetracyclines, contd. Pharmacokinetics Substitutions on these rings are responsible for variation in the drugs‘ individual pharmacokinetics. Thus tetracyclines mainly differ in their absorption after oral administration and their elimination, causing small differences in their clinical efficacy Absorption after oral administration is approximately 30% for chlortetracycline; 60– 70% for tetracycline, oxytetracycline, demeclocycline, and methacycline; and 95– 100% for doxycycline and minocycline A portion of an orally administered dose of tetracycline remains in the gut lumen, modifies intestinal flora, and is excreted in the feces Absorption occurs mainly in the upper small intestine and is impaired by food (except doxycycline and minocycline); by divalent cations (Ca2+, Mg2+, Fe2+) or Al3+; by dairy products and antacids, which contain multivalent cations, …..so! The decreased absorption results from chelation of divalent and trivalent cations Tetracyclines are 40–80% bound by plasma proteins. They are distributed widely to tissues and body fluids except for CSF (levels are 10–25% of those in serum) Minocycline reaches very high concentrations in tears and saliva, which makes it useful for eradication of the meningococcalcarrier state

Inhibitors of bacterial protein synthesis, Tetracyclines, contd. Pharmacokinetics, contd. Tetracyclines cross the placenta to reach the fetus and are also excreted in milk. As a result of chelation with calcium, tetracyclines are bound to—and damage—growing bones and teeth Tetracyclines are excreted mainly in urine (mainly by glomerular filtration) and bile; Small % of the these drugs are excreted in feces. Some of the drug excreted in bile is reabsorbed from the intestine (enterohepatic circulation) and contributes to maintenance of serum levels Doxycycline, in contrast to other tetracyclines, is eliminated by nonrenal mechanisms (excreted in feces), does not accumulate significantly in renal failure, and requires no dosage adjustment, making it the tetracycline of choice for use in the setting of renal insufficiency Minocycline is recovered from urine and feces in significantly lower amounts than are the other tetracyclines, and it appears to be metabolized to a considerable extent Its renal clearance is low. The drug persists in the body long after its administration is stopped, possibly due to retention in fatty tissues. Nonetheless, its half-life is not prolonged in patients with hepatic failure